Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P. (2005). Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Annals of the Rheumatic Diseases, 64(Suppl 2), ii14–ii17.
PubMed
PubMed Central
Google Scholar
Coates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta-Felquer, M., Armstrong, A. W., et al. (2016). Group for Research and Assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis & Rhematology, 68(5), 1060–1071.
Google Scholar
Gudu, T., Etcheto, A., de Wit, M., Heiberg, T., Maccarone, M., Balanescu, A., et al. (2016). Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. Joint, Bone, Spine, 83(4), 439–443. https://doi.org/10.1016/j.jbspin.2015.07.017.
Article
PubMed
Google Scholar
Orbai, A. M., de Wit, M., Mease, P., Shea, J. A., Gossec, L., Leung, Y. Y., et al. (2017). International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Annals of the Rheumatic Diseases, 76(4), 673–680.
Article
Google Scholar
Orbai, A. M., de Wit, M., Mease, P. J., Callis Duffin, K., Elmamoun, M., Tillett, W., et al. (2017). Updating the psoriatic arthritis (PsA) Core domain set: A report from the PsA workshop at OMERACT 2016. The Journal of Rheumatology, 44(10), 1522–1528.
Article
Google Scholar
Gladman, D., Fleischmann, R., Coteur, G., Woltering, F., & Mease, P. J. (2014). Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study. Arthritis Care and Research, 66(7), 1085–1092.
Article
CAS
Google Scholar
Strand, V., Schett, G., Hu, C., & Stevens, R. M. (2013). Patient-reported health-related quality of life with apremilast for psoriatic arthritis: A phase II, randomized, controlled study. The Journal of Rheumatology, 40(7), 1158–1165.
Article
CAS
Google Scholar
Strand, V., Mease, P., Gossec, L., Elkayam, O., van den Bosch, F., Zuazo, J., et al. (2017). Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: Results from a randomised phase III trial (FUTURE 1). Annals of the Rheumatic Diseases, 76(1), 203–207.
Article
CAS
Google Scholar
FDA. Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. 2009. https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf. Accessed 18 Jan 2019.
Revicki, D., Cella, D., Hays, R., Sloan, J., Lenderking, W., Aaronson, N. (2006) Responsiveness and minimal important differences for patient reported outcomes. Health and Quality of Life Outcomes, 4(70). http://www.hqlo.com/content/4/1/70
Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K., et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research, 9(8), 887–900.
Article
CAS
Google Scholar
Cella, D., Yount, S., Sorensen, M., Chartash, E., Sengupta, N., & Grober, J. (2005). Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. The Journal of Rheumatology, 32(5), 811–819.
PubMed
Google Scholar
Pouchot, J., Kherani, R. B., Brant, R., Lacaille, D., Lehman, A. J., Ensworth, S., et al. (2008). Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. Journal of Clinical Epidemiology, 61(7), 705–713.
Article
Google Scholar
Chandran, V., Bhella, S., Schentag, C., & Gladman, D. D. (2007). Functional Assessment of Chronic Illness Therapy-Fatigue scale is valid in patients with psoriatic arthritis. Annals of the Rheumatic Diseases, 66(7), 936–939.
Article
Google Scholar
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the functional assessment of Cancer therapy (FACT) measurement system. Journal of Pain and Symptom Management, 13(2), 63–74.
Article
CAS
Google Scholar
Cella, D., Lai, J. S., & Stone, A. (2011). Self-reported fatigue: One dimension or more? Lessons from the functional assessment of chronic illness therapy--fatigue (FACIT-F) questionnaire. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 19(9), 1441–1450. https://doi.org/10.1007/s00520-010-0971-1.
Article
Google Scholar
Rothman, M., Burke, L., Erickson, P., Leidy, N. K., Patrick, D. L., & Petrie, C. D. (2009). Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value in Health, 12(8), 1075–1083. https://doi.org/10.1111/j.1524-4733.2009.00603.x.
Article
PubMed
Google Scholar
Kaiser, K., Shaunfield, S., Clayman, M. L., Ruderman, E., & Cella, A. (2016). Content validation of the functional assessment of chronic illness therapy (FACIT)-fatigue scale in moderately to highly active rheumatoid arthritis. Rheumatology Current Research, 6(2). https://doi.org/10.4172/2161-1149.1000193
Friese, S., & Ringmayr, T. (2013). ATLAS.ti 7 user guide and reference. Berlin: ATLAS.ti Scientific Software Development GmBH.
Google Scholar
Willis, G. (2015). Analysis of the cognitive interview in questionnaire design. Understanding qualitative research. New York: Oxford University Press.
Google Scholar
Welch, L. C., Trudeau, J. J., Silverstein, S. M., Sand, M., Henderson, D. C., & Rosen, R. C. (2017). Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophrenia. Patient Related Outcome Measures, 8, 71–81. https://doi.org/10.2147/PROM.S123266.
Article
PubMed
PubMed Central
Google Scholar
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., et al. (2011). Content validity—Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1—Eliciting concepts for a new PRO instrument. Value in Health, 14(8), 967–977. https://doi.org/10.1016/j.jval.2011.06.014.
Article
PubMed
Google Scholar
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., et al. (2011). Content validity—Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2—Assessing respondent understanding. Value in Health, 14(8), 978–988. https://doi.org/10.1016/j.jval.2011.06.013.
Article
PubMed
Google Scholar
Boeije, H. (2002). A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Quality and Quantity, 36(4), 391–409. https://doi.org/10.1023/A:1020909529486.
Article
Google Scholar
Leidy, N. K., & Vernon, M. (2008). Perspectives on patient-reported outcomes : Content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics, 26(5), 363–370.
Article
Google Scholar
Mease, P., Hall, S., Fitzgerald, O., van der Heijde, D., Merola, J. F., Avila-Zapata, F., et al. (2017). Tofacitinib or adalimumab versus placebo for psoriatic arthritis. The New England Journal of Medicine, 377(16), 1537–1550.
Article
CAS
Google Scholar
Gladman, D., Rigby, W., Azevedo, V. F., Behrens, F., Blanco, R., Kaszuba, A., et al. (2017). Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors. The New England Journal of Medicine, 377(16), 1525–1536.
Article
CAS
Google Scholar
Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22(8), 1889–1905. https://doi.org/10.1007/s11136-012-0344-y.
Article
PubMed
Google Scholar
McDowell, I. (2006). Measuring health: A guide to rating scales and questionnaires. USA: Oxford University Press.
Book
Google Scholar
Tveter, A. T., Dagfinrud, H., Moseng, T., & Holm, I. (2014). Measuring health-related physical fitness in physiotherapy practice: Reliability, validity, and feasibility of clinical field tests and a patient-reported measure. The Journal of Orthopaedic and Sports Physical Therapy, 44(3), 206–216. https://doi.org/10.2519/jospt.2014.5042.
Article
PubMed
Google Scholar
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. https://doi.org/10.1097/01.Mlr.0000062554.74615.4c.
Article
PubMed
Google Scholar
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585. https://doi.org/10.1586/14737167.4.5.581.
Article
Google Scholar
Overman, C. L., Kool, M. B., da Silva, J. A., & Geenen, R. (2016). The prevalence of severe fatigue in rheumatic diseases: An international study. Clinical Rheumatology, 35(2), 409–415.
Article
Google Scholar
Gossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., et al. (2014). A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the psoriatic arthritis impact of disease (PsAID) questionnaire, a 13-country EULAR initiative. Annals of the Rheumatic Diseases, 73(6), 1012–1019.
Article
Google Scholar
Palimaru, A. I., Cunningham, W. E., Dillistone, M., Vargas-Bustamante, A., Liu, H., & Hays, R. D. (2018). Development and psychometric evaluation of a fatigability index for full-time wheelchair users with spinal cord injury. Archives of Physical Medicine and Rehabilitation. https://doi.org/10.1016/j.apmr.2018.04.003.
Article
Google Scholar
Hays, R. D., & Hadorn, D. (1992). Responsiveness to change: An aspect of validity, not a separate dimension. Quality of Life Research, 1(1), 73–75.
Article
CAS
Google Scholar
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., et al. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63(7), 737–745. https://doi.org/10.1016/j.jclinepi.2010.02.006.
Article
PubMed
Google Scholar
Gladman, D. D., Bombardier, C., Thorne, C., Haraoui, B., Khraishi, M., Rahman, P., et al. (2011). Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: The REPArE trial. The Journal of Rheumatology, 38(7), 1355–1362. https://doi.org/10.3899/jrheum.100698.
Article
CAS
PubMed
Google Scholar
Paul, C., van de Kerkhof, P., Puig, L., Unnebrink, K., Goldblum, O., & Thaci, D. (2012). Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: Subanalysis of the BELIEVE study. European Journal of Dermatology, 22(6), 762–769. https://doi.org/10.1684/ejd.2012.1863.
Article
CAS
PubMed
Google Scholar
Sloan, J. A., Cella, D., & Hays, R. D. (2005). Clinical significance of patient-reported questionnaire data: Another step toward consensus. Journal of Clinical Epidemiology, 58(12), 1217–1219.
Article
Google Scholar
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109.
Article
Google Scholar
Beaton, D. E., Bombardier, C., Katz, J. N., Wright, J. G., Wells, G., Boers, M., et al. (2001). Looking for important change/differences in studies of responsiveness. OMERACT MCID working group. Outcome measures in rheumatology. Minimal clinically important difference. The Journal of Rheumatology, 28(2), 400–405.
CAS
PubMed
Google Scholar
Wells, G., Beaton, D., Shea, B., Boers, M., Simon, L., Strand, V., et al. (2001). Minimal clinically important differences: Review of methods. The Journal of Rheumatology, 28(2), 406–412.
CAS
PubMed
Google Scholar
Cella, D., Eton, D. T., Lai, J. S., Peterman, A. H., & Merkel, D. E. (2002). Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of Cancer therapy (FACT) anemia and fatigue scales. Journal of Pain and Symptom Management, 24(6), 547–561.
Article
Google Scholar
Cella, D., Lai, J. S., Jensen, S. E., Christodoulou, C., Junghaenel, D. U., Reeve, B. B., et al. (2016). PROMIS fatigue item Bank had clinical validity across diverse chronic conditions. Journal of Clinical Epidemiology, 73, 128–134.
Article
Google Scholar
Bartlett, S. J., Gutierrez, A. K., Butanis, A., Bykerk, V. P., Curtis, J. R., Ginsberg, S., et al. (2018). Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis. Quality of Life Research. https://doi.org/10.1007/s11136-018-1880-x.
Article
CAS
Google Scholar